ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #12,173Hybrid

Regenerative Medicine

Abbreviation (ISO):REGEN MED
•
Identifier (ISSN):1746-0751(Print)/1746-076X(Online)
•
Publisher:Future Medicine Ltd.
Clarivate IF (2026)
3↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Regenerative Medicine

WoS Q3
12452.9920182.3820192.620203.8120213.2120222.720232.420242.6202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q2
0.487
#12,173

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
80

80 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate8.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
71articles/year
16.79% Gold OA•67.24% Original Research

Aims & Scope

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization. Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community. Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

Topics Covered (Recognized by AI)
Biology87.7%Genetics79.7%Medicine76.6%Cell biology73%Chemistry69.1%Biochemistry65.8%Stem cell61.3%Cell42.5%Internal medicine41.2%Pathology37.9%Regenerative medicine32.6%Engineering30.7%Gene26.8%Computer science26.7%Surgery26.6%Immunology22.5%Psychology22.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q3
Rank21/32
IndexSCIE
JCRSCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank69/130
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q4
Rank26/32
IndexSCIE
JCISCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank91/130
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year38
Total Citations8
2025
IF2.6
Articles / Year64
Total Citations113
2024
IF2.4
Articles / Year58
Total Citations177
2023
IF2.7
Articles / Year96
Total Citations661
2022
IF3.21
Articles / Year111
Total Citations632

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,173Scopus Q2SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:EngineeringMedicine
Scopus Citation Rank (SJR)Q2
0.487

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.42

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,930 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations461
3-Year Documents205
Citable Documents178

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate35.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EmbryologyQ2
Biomedical EngineeringQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Regenerative Medicine (abbr: REGEN MED, ISSN: 1746-0751) is a peer-reviewed international scholarly journal in the field of Medicine, published by Future Medicine Ltd. in England since 2006. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.487 (Q2), an H-index of 80.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 71 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,930 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Future Medicine Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
2006
Indexing & Databases
SCIEScopusPubMed
Editorial Address
FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fca53afd-966b-447d-be62-7a03303b029a
Database Updated: 2026-10-01